Oligonucleotide inhibitors of Dnmt1: penetration and Hela and Caski cells growth inhibition | Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya - Tomsk State University Journal of Biology. 2015. № 1 (29) . DOI: 10.17223/19988591/29/10

Oligonucleotide inhibitors of Dnmt1: penetration and Hela and Caski cells growth inhibition

The use of Dnmt1 inhibitors allows reactivation of tumor suppressor genes which leads to tumor regression. Currently used drugs have potent toxic and mutagenic effect despite their high effectiveness. Thus, the development of Dnmt1 direct inhibitors with antitumor activity and moderate effect on normal cells remains relevant. Recently we have designed and synthesized competitive oligodeoxyribonucleotide inhibitors of human Dnmt1 demonstrating their ability to inhibit DNA methylation reaction in vitro. The aim of our work was to study the influence of the best of Dnmt1 inhibitors on the cervix carcinoma cells growth. We used cell lines HeLa, CaSki and L-68 from SRC VB "Vector" (Russia) collection. Oligonucleotides were transfected using Lipofectamine 2000 "Invitrogen" (USA) according to the manufacturer's instructions. The localization of fluorescent labeled oligonucleotides in the cells was evaluated by fluorescence microscopy. Toxic effect was evaluated by spectrophotometry. TC 50values (50% cytotoxic concentration) were calculated from the number of living cells depending on the inhibitor concentration in the medium. We studied fluorescent labeled oligonucleotides localization with oligonucleotides which are similar to inhibitors but have no Dmnt1 inhibition properties. After transfection the oligonucleotides are localized in cell nuclei, and there is no apparent luminescence reduction within 48 hours. This was achieved due to phosphates tophosphothioates replacement that allows a long-term presence of the inhibitor in the cell nucleus. The combination of structural features, such as C: A non-complementary and "pin" had a cumulative effect. Thus, the best TC 50 values were obtained from inhibitors that possess all of these modifications. The presence of unpaired nucleotides in the double-stranded DNA recognition site greatly enhances the ability to inhibit the methylation reaction. Despite the fact that both investigated cervical carcinomas are associated with human papillomavirus (Hela with HPV-18, Caski with HPV-16), the effect of inhibitors occurs with different efficiency: TC 50 values ranged 236-408 nM for HeLa cell line and 118170 nM for CaSki cell line. At the same time, TC 50 value for fibroblast cell line L-68 exceeded 10 ^M for all tested inhibitors which makes them promising for a further study as antitumor drugs.

Download file
Counter downloads: 53

Keywords

метилирование ДНК, ингибиторы ДНК-метилтрансфераз, карцинома шейки матки, DNA methylation, DNA methyltransferases inhibitors, cervical cancer

Authors

NameOrganizationE-mail
Kuznetsov Vitaliy V.State Research Center of Virology and Biotechnology "VECTOR" (Koltsovo, Novosibirsk Region)kuznetsov_vv@vector.nsc.ru
Evdokimov Alexey A.State Research Center of Virology and Biotechnology "VECTOR" (Koltsovo, Novosibirsk Region)evdokimov@vector.nsc.ru
Netesova Nina A.State Research Center of Virology and Biotechnology "VECTOR" (Koltsovo, Novosibirsk Region)ninanet@vector.nsc.ru
Всего: 3

References

Vilkaitis G., Suetake I., Klimasauskas S., Tajima S. Processive methylation ofhemimethylated CpG sites by mouse Dnmt1 DNA methyltransferase // J. Biol. Chem. 2005. Vol. 280, № 1. P. 64-72.
Hermann A., Goyal R., Jeltsch A. The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites // J. Biol. Chem. 2004. Vol. 279, № 46. P. 48350-48359.
Goyal R., Reinhardt R., Jeltsch A. Accuracy of DNA methylation pattern preservation by the Dnmt1 methyltransferase // Nucleic Acids Res. 2006. Vol. 34, № 4. P. 1182-1188.
Радаева И.Ф., Нечаева Е.А., Дроздов И.Г. Коллекция культур клеток ФГУН ГНЦ ВБ «Вектор» Роспотребнадзора. Новосибирск : ЦЭРИС, 2009. 251 с.
Евдокимов А.А., Зиновьев В.В., Кузнецов В.В., Нетесова Н.А., Малыгин Э.Г. Конструирование олигонуклеотидных ингибиторов ДНК-метилтрансферазы 1 человека // Молекулярная биология. 2009. Т. 43, № 3. C. 455-463.
Singh V., Sharma P., Capalash N. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer // Curr. Cancer Drug Targets. 2013. Vol. 13, № 4. P. 379-399.
Jones P.A., Baylin S.B. The epigenomics of cancer // Cell. 2007. Vol. 128, № 4. P. 683-692.
Акишев А.Г., Гончар Д.А., Абдурашитов М.А., Дегтярев С.Х. Эпигенетическое типирование малигнантных клеточных линий человека с помощью Bls- и GlaI-ПЦР анализа // Вестник биотехнологии и физико-химической биологии им. Ю.А. Овчинникова. 2011. Т. 5, № 7. P. 5-12.
Moore L.D., Le T., Fan G. DNAmethylation and its basic function //Neuropsychopharmacology. 2013. Vol. 38, № 1. P. 23-38.
Delpu Y., Cordelier P., Cho W.C., Torrisani J. DNA methylation and cancer diagnosis // Int. J. Mol. Sci. 2013. Vol. 14, № 7. P. 15029-15058.
Jurkowska R.Z., Jurkowski T.P., Jeltsch A. Structure and function of mammalian DNA methyltransferases // Chembiochem. 2011. Vol. 12, № 2. P. 206-222.
 Oligonucleotide inhibitors of Dnmt1: penetration and Hela and Caski cells growth inhibition | Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya - Tomsk State University Journal of Biology. 2015. № 1 (29) . DOI:  10.17223/19988591/29/10

Oligonucleotide inhibitors of Dnmt1: penetration and Hela and Caski cells growth inhibition | Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya - Tomsk State University Journal of Biology. 2015. № 1 (29) . DOI: 10.17223/19988591/29/10

Download full-text version
Counter downloads: 1531